Lazar Florin-Leontin, Ielasi Alfonso, Cortese Bernardo
San Carlo Clinic, Paderno Dugnano, Milan, Italy.
Istituto Clinico Sant'Ambrogio, Milan, Italy.
Minerva Cardiol Angiol. 2022 Dec;70(6):689-696. doi: 10.23736/S2724-5683.22.06061-6. Epub 2022 Mar 28.
Coronary lesions predilatation with semicompliant (SC) or non-compliant balloons (NC) may be insufficient to obtain an optimal stent expansion, which can lead to in-stent restenosis or thrombosis. Moreover, increasing evidence supporting an optimal lesion preparation is mandatory when drug coated balloons (DCB) are used. To this extent, more "aggressive tools" such as cutting/scoring balloons, atherectomy or lithotripsy may play an important role and improve outcomes.
We enrolled 78 consecutive patients from March 2020 to October 2020 with calcific/fibrotic or ostially-located lesions, which were prepared using scoring balloons, in addition to SC/NC balloons and other plaque modification strategies. The final treatment consisted in either stent or DCB usage. The primary endpoint was the rate of clinically-driven target lesion revascularization. Secondary endpoints entailed the procedural success and the individual rates of major adverse cardiac events (MACE) at 12 months.
Most of the patients had left main (LM) or ostial lesions, 65% of them being moderate/severely calcified, with further debulking strategies being required in 15 (19.2%) patients (rotational atherectomy, 3.8% or coronary intravascular lithotripsy, 15.3%). A high-rate of DCB usage was reported. Angiographic and procedural success was obtained in 77 and 76 patients, respectively. We encountered one vessel perforation, which was sealed with a covered stent, without consequence. During follo- up, we observed only 6 MACE, 6 target lesion revascularizations (TLR) and 2 cardiovascular deaths.
Among patients with high complexity and calcific lesions, an optimal lesion preparation using a dedicated scoring balloon was associated with low clinical events at mid-term follow-up and may be considered to improve immediate procedural success rate.
使用半顺应性(SC)或非顺应性球囊(NC)对冠状动脉病变进行预扩张可能不足以实现最佳的支架扩张,这可能导致支架内再狭窄或血栓形成。此外,越来越多的证据表明,使用药物涂层球囊(DCB)时,进行最佳的病变预处理是必不可少的。在这方面,诸如切割/刻痕球囊、旋切术或碎石术等更“激进的工具”可能发挥重要作用并改善治疗效果。
我们纳入了2020年3月至2020年10月期间连续的78例患有钙化/纤维化或开口处病变的患者,除了使用SC/NC球囊和其他斑块修饰策略外,还使用刻痕球囊对病变进行预处理。最终治疗包括使用支架或DCB。主要终点是临床驱动的靶病变血运重建率。次要终点包括手术成功率和12个月时主要不良心脏事件(MACE)的个体发生率。
大多数患者患有左主干(LM)或开口处病变,其中65%为中度/重度钙化,15例(19.2%)患者需要进一步的减容策略(旋磨术,3.8%或冠状动脉血管内碎石术,15.3%)。报告了较高的DCB使用率。分别有77例和76例患者获得了血管造影和手术成功。我们遇到1例血管穿孔,用覆膜支架封堵,未造成后果。在随访期间,我们仅观察到6例MACE、6例靶病变血运重建(TLR)和2例心血管死亡。
在具有高度复杂性和钙化病变的患者中,使用专用刻痕球囊进行最佳的病变预处理与中期随访时较低的临床事件相关,并且可能被认为可提高即刻手术成功率。